With the decrease in disease activity, levels of TGF-β1 (p < 0.0001; Fig. 1e) and PDGF-B (p = 0.0255; Fig. 1f) in SLE patients decreased greatly. This evidence concerns the gene TGFB1 and systemic lupus erythematosus.